A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT01089023 · COMPLETED
Trial details
- NCT number
- NCT01089023
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.